Encellin
PrivateLast Round
Series A
Dec 13, 2023
Est. Valuation
$2.14M
Total Funding Raised
$15.95M
Company Overview
Encellin is a biotechnology company that develops an innovative thin-film cell encapsulation device for cell-based therapeutics to treat type 1 diabetes and other endocrine disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Encellin Comparables
Compare Encellin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seraxis | 86% | |
| Sernova Biotherapeutics Inc. | 83% | |
| Betalin Therapeutics | 82% | |
Encellin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 13, 2023 | ||||
| Seed | Aug 5, 2021 | ||||
| Accelerator | Aug 20, 2019 |
Key People
Founding team and executive leadership
Encellin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Seed, Series A |
| Y Combinator | Seed, Series A, Accelerator |
| SV Latam Capital | Seed |
| Sand Hill Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 13, 2023
$10M round led by Khosla Ventures
- Aug 5, 2021
$6M round led by Khosla Ventures and SV Latam Capital.
Encellin Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Encellin's valuation, stock price, and market status.